Xoma News (NASDAQ:XOMA)

Latest Xoma News Headlines
DateTimeSource
Headline
04/26/20075:56PMPRNUSHealthShares(TM) Announces Changes to the HealthShares(TM) Dermatology & Wound Care, Emerging Cancer, and Composite Indexes
NEW YORK, April 26 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Indexes, that effective at the opening of trading on Monday April 30, 2007, Integra... More...>>
09/28/20069:00AMPRNUSAVEO and XOMA Enter Into Supply Agreement for AVEO's Novel Anti-HGF Antibody
Contract Follows Successful Human Engineering(TM) of AV-299 BERKELEY, Calif., and CAMBRIDGE, Mass., Sept. 28 /PRNewswire-FirstCall/ -- XOMA Ltd. (NASDAQ:XOMA) and AVEO Pharmaceuticals, Inc. (AVEO) today announced a $6 million agreement under which XOMA will manufacture and supply AV-299, AVEO's novel anti-HGF antibody... More...>>
04/27/20068:00AMPRNUSXOMA and AVEO Announce Agreement to Apply Human Engineering(TM) Technology to AV-299, AVEO's Novel Anti-HGF Antibody
Human Engineering(TM) Technology to Accelerate Development of Clinical Candidate BERKELEY, Calif. and CAMBRIDGE, Mass., April 27 /PRNewswire/ -- XOMA Ltd. (NASDAQ:XOMA) and AVEO Pharmaceuticals, Inc. (AVEO) today announced an agreement for XOMA to utilize its Human Engineering(TM) (HE(TM)) technology to humanize AV-299... More...>>
06/21/20057:30AMPRNUSLexicon Genetics and XOMA Establish Collaboration for Antibody Drug Development and Commercialization
Lexicon Genetics and XOMA Establish Collaboration for Antibody Drug Development and Commercialization THE WOODLANDS, Texas; BERKELEY, Calif., June 21 /PRNewswire-FirstCall/ -- Lexicon Genetics Incorporated (NASDAQ:LEXG) and XOMA Ltd. (NASDAQ:XOMA) announced today the formation of a collaboration to jointly develop and commercialize... More...>>
06/01/20056:30AMPRNUSDiversa Achieves Milestone Under XOMA Antibody Agreement
Diversa Achieves Milestone Under XOMA Antibody Agreement For Generation of High-Affinity Antibody Product Candidate SAN DIEGO and BERKELEY, Calif., June 1 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA) and XOMA Ltd. (NASDAQ:XOMA) today announced the achievement of a milestone under their therapeutic antibody... More...>>
03/22/20041:00AMPRNUSGenentech and XOMA Announce Results Of Phase II Study of Raptiva(TM) in Psoriatic Arthritis Patients
Genentech and XOMA Announce Results Of Phase II Study of Raptiva(TM) in Psoriatic Arthritis Patients SOUTH SAN FRANCISCO, and BERKELEY, Calif., March 22 /PRNewswire-FirstCall/ -- Genentech, Inc. and XOMA Ltd. today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVATM (efalizumab... More...>>
03/16/20041:00AMPRNUSRaptiva(R) (Efalizumab) Receives Approval for Moderate-to-Severe Plaque Psoriasis in Switzerland
Raptiva(R) (Efalizumab) Receives Approval for Moderate-to-Severe Plaque Psoriasis in Switzerland First Approval of Raptiva for Serono GENEVA, March 16 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) announced today that Raptiva(R) (efalizumab) has been approved by Swissmedic, the Swiss regulatory authority... More...>>
03/01/20047:30AMPRNUSChiron and XOMA Form Collaboration For Development and Commercialization Of Therapeutic Antibodies For Cancer
Chiron and XOMA Form Collaboration For Development and Commercialization Of Therapeutic Antibodies For Cancer - Agreement Leverages Companies' Strengths in Oncology, Antibody Discovery and Product Development - EMERYVILLE, Calif., and BERKELEY, Calif., March 1 /PRNewswire-FirstCall/ -- Chiron Corporation and XOMA Ltd... More...>>
12/18/20036:30AMPRNUSAlexion Pharmaceuticals and XOMA Form Collaboration
Alexion Pharmaceuticals and XOMA Form Collaboration - Product Development Efforts to Focus on TPO Mimetic Antibody - CHESHIRE, Conn. and BERKELEY, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. and XOMA Ltd. today announced a collaborative agreement for the development and commercialization... More...>>
11/13/20031:43PMPRNUSPacific Exchange to Trade Three New Options
Pacific Exchange to Trade Three New Options SAN FRANCISCO, Nov. 13 /PRNewswire/ -- The Pacific Exchange (PCX) announced that on Friday, November 14, 2003, it will begin trading options on Alcoa, Inc. ; Valero Energy Corp. ; and XOMA Ltd. . Alcoa options will trade on the January expiration cycle with exercise limits set... More...>>
10/28/20031:13PMPRNUSCuraScript Pharmacy Signs Contract With Genentech For Distribution of RAPTIVA(TM)
CuraScript Pharmacy Signs Contract With Genentech For Distribution of RAPTIVA(TM) ORLANDO, Fla., Oct. 28 /PRNewswire-FirstCall/ -- CuraScript Pharmacy, Inc., the leading national specialty pharmacy, announced today that it has been selected by Genentech, Inc. to be a participating pharmacy in the Specialty Pharmacy Limited... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
33 site:2us nasdaq xoma080724 08:04 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )